T2 Biosystems, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
T2 Biosystems, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • T2 Biosystems, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $87.2M, a 0.69% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $87.2M -$607K -0.69% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $87.8M +$3.05M +3.59% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $84.8M +$12.4M +17.1% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $72.4M +$12.6M +21.2% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $59.8M -$30.6M -33.9% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $90.4M +$12.8M +16.5% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $77.5M -$6.38M -7.6% Dec 31, 2017 10-K 2019-03-14
Q4 2016 $83.9M +$22.1M +35.8% Dec 31, 2016 10-K 2018-03-19
Q4 2015 $61.8M +$18.9M +44.2% Dec 31, 2015 10-K 2017-03-15
Q4 2014 $42.9M +$12.7M +42.2% Dec 31, 2014 10-K 2016-03-09
Q4 2013 $30.1M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.